Related Experiment Video
Updated: Jul 28, 2026
07:41
Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
Published on: June 7, 2011
[Myocardial regeneration: future at reach].
J Gavira1, E Alegría, A Martín Arnau
1Departamento de Cardiología y Cirugia Cardiovascular, Facultad de Medicina, Universidad de Navarra, Pamplona. jjgavira@unav.es
Revista De Medicina De La Universidad De Navarra
|January 13, 2006
Summary
Cell transplantation shows promise for heart failure regenerative therapy. Clinical trials are now appropriate to assess the safety and efficacy of bone marrow derived cells for heart repair.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Cell-Based Therapies
Context:
- Growing interest in regenerative therapy for heart failure using cell transplantation.
- Early studies utilized skeletal myoblasts; recent focus on bone marrow derived cells yields mixed results.
- Ethical considerations and laboratory research are addressing safety and efficacy concerns.
Purpose:
- To evaluate the potential of cell transplantation in treating heart failure.
- To synthesize current research on bone marrow derived cells for cardiac regeneration.
- To determine the readiness for clinical trials in heart failure cell therapy.
Summary:
- Cell transplantation, particularly with bone marrow derived cells, is a key area in heart failure regenerative therapy.
- Despite conflicting experimental results and ethical questions, accumulated evidence supports clinical trial implementation.
- Initial clinical trials have confirmed feasibility, paving the way for safety and efficacy studies.
Impact:
- Provides a foundation for future clinical trials in cardiac regenerative medicine.
- Highlights the need for rigorous safety and efficacy assessments in cell therapy for heart failure.
- Contributes to understanding the clinical viability of cell-based approaches for myocardial repair.
